A study in EBioMedicine reveals significant microplastic concentrations in thrombi from major blood vessels, linking microplastic levels to increased risk and severity of thrombotic events.
Picture in your mind a traditional “landline” telephone with a coiled cord connecting the handset to the phone.
Acepodia, a clinical stage biotechnology company developing first-in-class cell therapies with its antibody-cell conjugation (ACC) and allogeneic gamma delta 2 T-cell platforms to address gaps